Lexicon Pharmaceuticals, Novo Nordisk strike obesity-drug license deal worth up to $1B
Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) said March 28 it will exclusively license its drug candidate LX9581 to Danish ...
Traws Pharma Announces Management Updates
Werner Cautreels, PhD, to retire as CEO, while continuing as a Board MemberIain D. Dukes, D Phil, Executive Board Chairman, to become Interim ...
US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
Traws Pharma CEO Werner Cautreels retires, Iain Dukes named interim CEO
Traws Pharma (TRAW) announced the retirement of Werner Cautreels, CEO, effective on or about close of business on March 31 after the company ...
Arbutus Biopharma: A Wing And A Prayer
Arbutus Biopharma restructures to cut costs & focus on Hepatitis B drug imdusiran. Read more about ABUS stock here.
Indiatimes7h
Akums Drugs & Pharma Share Price Returns
Akums Drugs & Pharmaceuticals Ltd., incorporated in the year 2004, is a company (having a market cap of Rs 7,412.47 Crore) operating in Pharmaceuticals sector. Akums Drugs & Pharmaceuticals Ltd. key ...
Indiatimes10h
Nifty Pharma
Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends in the pharmaceutical sector.